Roivant Sciences Ltd.

NASDAQ (USD): Roivant Sciences Ltd. (ROIV)

Last Price

10.73

Today's Change

-0.10 (0.92%)

Day's Change

10.71 - 11.15

Trading Volume

9,499,993

Overview

Market Cap

8 Billion

Shares Outstanding

805 Million

Avg Volume

6,689,304

Avg Price (50 Days)

10.94

Avg Price (200 Days)

10.62

PE Ratio

2.06

EPS

5.20

Earnings Announcement

26-Jun-2024

Previous Close

10.83

Open

11.12

Day's Range

10.715 - 11.1593

Year Range

8.245 - 13.24

Trading Volume

9,499,993

Price Change Highlight

1 Day Change

-0.92%

5 Day Change

-1.92%

1 Month Change

-1.56%

3 Month Change

-6.21%

6 Month Change

12.24%

Ytd Change

-5.46%

1 Year Change

18.30%

3 Year Change

8.82%

5 Year Change

3.17%

10 Year Change

3.17%

Max Change

3.17%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment